Podcasts about seizure medication

Dr. Halley Alexander, Dr. Genevieve Rayner, and Eliza Honybun discuss the relationship between prenatal antiseizure medication exposure and adverse postnatal neurodevelopmental outcomes. Show reference:  

Dr. Halley Alexander talks with Dr. Genevieve Rayner and Eliza Honybun about the relationship between prenatal antiseizure medication exposure and adverse postnatal neurodevelopmental outcomes.  Disclosures can be found at Neurology.org.

In this episode, we will delve into the important general aspects of anti-seizure drug use in cats and dogs. We will review 5 important questions - 1 – How aggressive should our diagnostic evaluation be? 2 – How should I choose a medication for my patient 3 - How long will it take for the drugs to work 4 – What monitoring should be done in the individual dog or cat 5 – How do I know when to add a second anti-seizure medication Join us to listen to the answers to these questions which get us ready to begin the seizure therapy journey.

In this episode, we review why we need to consider medications for our epileptic pets and what indications there are to determine the most appropriate time to start the drugs. Owner and pet quality of life has to be our focus before and after starting medications and so as we will discuss, this becomes a joint decision-making process with the pet carers.

Dr. Irfan Sheikh sheds light on the usage of anti-seizure medications within the inpatient setting.

Claire is joined by reporter Brian O'Connell on the availability of Rivotril.

This episode is also available as a blog post: https://fierceautie.com/2022/09/25/bogus-study-association-of-prenatal-exposure-to-anti-seizure-medication-with-risk-of-autism-and-intellectual-disability/ --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app Support this podcast: https://anchor.fm/fierceautie/support

Today we talk to Samuel Terman; an epileptologist and researcher from the University of Michigan, USA, who specialises in helping people affected by seizures and epilepsy. Samuel tells us about his research into adherence to medications, polypharmacy, deprescribing, and the high rate of multiple disabilities amongst those with epilepsy. Samuel's work focuses on optimising the delivery of medical care for patients with epilepsy, through medication decisions, hospital utilisation and readmissions, and inpatient seizure monitoring quality of care.---Glossary: There are many terms used in this recording which you can find in the Epilepsy Sparks Glossary (useful for clinicians as well as patients/families): here: ww.epilepsysparks.com/glossary ---More about Samuel: www.torierobinson.com/epilepsy-sparks-insights/samuel-terman---Glossary:There are many terms used in this recording which you can find in the Epilepsy Sparks Glossary: https://www.epilepsysparks.com/glossary---Follow Torie on:Twitter: https://twitter.com/torierobinson10LinkedIn: https://www.linkedin.com/torierobinsonInstagram: https://www.instagram.com/torierobinson10Facebook: https://www.facebook.com/TorieRobinsonSpeakerCheck out the website: https://www.torierobinson.com

  In this installment of the NCS Podcast, Dr. Michael Brogan interviews Dr. Andrew Naidech on their paper evaluating quality of life measures in patients who receive prophylactic levetiracetam for seizure prevention following intracerebral hemorrhage. The NCS Podcast is the official podcast of the Neurocritical Care Society. Our senior producer is Jim Siegler. Our host is Fawaz Almufti, and our production staff includes Ramani Balu, Michael Brogan, Joshua Levine, Sarah Stern-Nezer, Benjamin Miller, Starane Shepherd, and Chris Zammit. Our administrative staff include Becca Stickney, Sara Memmen, and Angel Gindele. Music by Lee Roosevere. Naidech AM, Beaumont J, Muldoon K, Liotta EM, Maas MB, Potts MB, et al. Prophylactic seizure medication and health-related quality of life after intracerebral hemorrhage. Crit Care Med. 2019;46(9):1480-1485.  

Rhonda Agard describes how an unforeseen freak accident changed her life forever. Lost in a sea of Opiates and Seizure Medication she describes how Cannabis was able to give her back her life. Are you ready to Consider Cannabis?

In this week's episode of Epilepsy.com's Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com/Professionals, interviews David Ficker, MD, Associate Professor of Neurology, University of Cincinnati Medical Center about Choosing an a Seizure Medication. This is a live taping with no questions to be answered live.

In this week's episode of Epilepsy.com's Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com/Professionals, interviews Dr. Scott Mintzer, Associate Professor of Neurology, Director, Epilepsy Monitoring Unit and Epilepsy Surgery Program, Jefferson Comprehensive Epilepsy Center, Thomas Jefferson University on Antiseizure medications and Metabolism: Can seizure medications impact cholesterol levels? This is a live taping with no questions to be answered live.

Increasing concerns about depression, suicidality, and other mood problems have been seen in people with epilepsy for many years. While recent information from the U.S. FDA suggests antiepileptic drugs (AEDs) as a possble cause, the links between the brain, epilepsy, AEDs and other treatments are complex and not well understood. Patricia Shafer, Resource Specialist on epilepsy.com will interview Dr. Andres Kanner, a well-known epileptologist and neuropsychiatrist about this topic.